CN114729001A - 一种齐墩果烷苯丙烯酰胺衍生物及其制备方法和用途 - Google Patents

一种齐墩果烷苯丙烯酰胺衍生物及其制备方法和用途 Download PDF

Info

Publication number
CN114729001A
CN114729001A CN202080079360.9A CN202080079360A CN114729001A CN 114729001 A CN114729001 A CN 114729001A CN 202080079360 A CN202080079360 A CN 202080079360A CN 114729001 A CN114729001 A CN 114729001A
Authority
CN
China
Prior art keywords
cyano
cancer
compound
dioxooleanane
dien
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080079360.9A
Other languages
English (en)
Inventor
张贵民
梁红宝
陈莉
赵桂芳
赵子豪
卢小艳
孙成宏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lunan Pharmaceutical Group Corp
Original Assignee
Lunan Pharmaceutical Group Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lunan Pharmaceutical Group Corp filed Critical Lunan Pharmaceutical Group Corp
Publication of CN114729001A publication Critical patent/CN114729001A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

涉及药物化学领域和药物治疗学领域,具体涉及一类2‑氰基‑3,12‑二氧代齐墩果烷‑1,9(11)‑二烯‑17‑苯丙烯酰胺衍生物及其制备方法;还涉及该类新化合物在制备抗癌药物中的应用。

Description

PCT国内申请,说明书已公开。

Claims (12)

  1. PCT国内申请,权利要求书已公开。
CN202080079360.9A 2019-11-27 2020-11-26 一种齐墩果烷苯丙烯酰胺衍生物及其制备方法和用途 Pending CN114729001A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2019111829675 2019-11-27
CN201911182967 2019-11-27
PCT/CN2020/131887 WO2021104391A1 (zh) 2019-11-27 2020-11-26 一种齐墩果烷苯丙烯酰胺衍生物及其制备方法和用途

Publications (1)

Publication Number Publication Date
CN114729001A true CN114729001A (zh) 2022-07-08

Family

ID=76130022

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080079360.9A Pending CN114729001A (zh) 2019-11-27 2020-11-26 一种齐墩果烷苯丙烯酰胺衍生物及其制备方法和用途

Country Status (6)

Country Link
US (1) US20230023332A1 (zh)
EP (1) EP4067367A4 (zh)
JP (1) JP2023504428A (zh)
KR (1) KR20220104734A (zh)
CN (1) CN114729001A (zh)
WO (1) WO2021104391A1 (zh)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009146216A2 (en) * 2008-04-18 2009-12-03 Reata Pharmaceuticals. Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
EA019263B1 (ru) * 2008-04-18 2014-02-28 Ритэ Фамэсутикл, Инк. Антиоксидативные модуляторы воспаления: производные олеанолевой кислоты с аминовыми и другими модификациями на с-17
BR112016003454B1 (pt) * 2013-08-23 2023-02-14 Reata Pharmaceuticals, Inc. Uso de composto de metil bardoxolona
MX2019005401A (es) * 2016-11-08 2019-08-05 Reata Pharmaceuticals Inc Metodos para tratar el sindrome de alport con bardoxolona metilo o analogos de la misma.
CN106632576A (zh) * 2016-12-16 2017-05-10 中国药科大学 2-氰基-3,12-二氧代齐墩果烷-1,9(11)-二烯-28-羧酸的合成方法改进

Also Published As

Publication number Publication date
US20230023332A1 (en) 2023-01-26
WO2021104391A1 (zh) 2021-06-03
JP2023504428A (ja) 2023-02-03
EP4067367A1 (en) 2022-10-05
KR20220104734A (ko) 2022-07-26
EP4067367A4 (en) 2024-04-10

Similar Documents

Publication Publication Date Title
EP3070089B1 (en) Aminomethyl tryptanthrin derivative, preparation method and application thereof
JP7128345B2 (ja) ジアリール大員環化合物、医薬組成物及びその用途
CN111393404B (zh) 一类苯并噻吩类化合物及其药物组合物及应用
US20150011536A1 (en) Antitumor aza-benzo [f] azulen derivative, method for preparing same, and use thereof
WO2016086824A1 (zh) 一种Bouchardatine和Bouchardatine衍生物及其制备方法和应用
US20220389006A1 (en) Salts and forms of an estrogen receptor modulator
CN111704646B (zh) 甾体类化合物及其制备方法和用途
WO2015096640A1 (zh) 含噻唑基雷帕霉素类衍生物及其应用
CN108947949B (zh) 抗焦虑氘代化合物及其医药用途
WO2022206705A1 (zh) 作为tyk2假激酶结构域抑制剂的杂环化合物及合成方法和用途
CN110372557B (zh) 环己烷胺类d3/d2受体部分激动剂
CN114729001A (zh) 一种齐墩果烷苯丙烯酰胺衍生物及其制备方法和用途
JP7329052B2 (ja) フッ素含有置換ベンゾチオフェン化合物ならびにその医薬組成物および応用
CN110981865B (zh) 一种用于治疗脑胶质瘤的药物及其制备方法
CN109748914B (zh) 吡啶并嘧啶类化合物及其应用
TWI419894B (zh) 4-苯胺基呋喃[2,3-b]喹啉衍生物,其製備方法以及包含有此等衍生物的藥學組成物
CN111892581A (zh) 一种具有抗肿瘤活性的喹唑啉类衍生物及其合成方法和用途
CN111138361B (zh) 取代苯氧基-2-氮杂双环[3.2.1]辛烷类化合物及其制备方法和应用
CN110066253B (zh) 1,2,5-噁二唑类衍生物,其制备方法及其在医药中的应用
CN110577501A (zh) 吲哚胺2,3-双加氧酶调节剂,其制备方法及用途
CN115572247B (zh) 一类维生素k3衍生物及其医药用途
CN113004268B (zh) 一种抑制肿瘤细胞生长的噻唑化合物及其用途
Xiao et al. Biologically active franchetine-type diterpenoid alkaloids: Isolation, synthesis, anti-inflammatory, agalgesic activities, and molecular docking
CN117304148A (zh) 3,4-二取代型γ-丁内酯衍生物及其制备方法和制备抗肿瘤药物的应用
CN115746017A (zh) 一种噻吩并嘧啶类化合物及其制备方法和应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination